Inventor · Paris, FR

Jose-Alain Sahel

44Patents
6h-index
100Co-inventors
72Inventor score

Filing activity: Jun 8, 2001 → May 26, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8114849B2 Retinal dystrophy-associated protein and uses thereof Chemistry; Metallurgy 10 Active
US8071745B2 Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same Chemistry; Metallurgy 10 Active
US8518695B2 Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 Chemistry; Metallurgy 10 Active
US8394756B2 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells Chemistry; Metallurgy 9 Active
US6716835B1 Use of diltiazem for treating retinal pathologies Human Necessities 9 Expired
US7795387B2 Rod-derived cone viability factor (RDCVF) and a method of enhancing cone cell survival by RDCVF Chemistry; Metallurgy 8 Expired
US9962540B2 Biocompatible carbon based electrode and its preparation process Performing Operations; Transporting 6 Active
US8957043B2 Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2 Chemistry; Metallurgy 4 Active
US9987167B2 Method and device for controlling a device for aiding vision Physics 3 Active
US9994815B2 Methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells Chemistry; Metallurgy 3 Active
US8779093B2 Neuronal viability factor and use thereof Human Necessities 3 Active
US9017999B2 Importation of mitochondrial protein by an enhanced allotopic approach Chemistry; Metallurgy 3 Active
US10004780B2 Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD) Chemistry; Metallurgy 2 Active
US8193153B2 Trophic factor for the treatment of retinal degenerative diseases Human Necessities 2 Active
US9575075B2 Methods for treating cone dystrophy with neuronal viability factor, RDCVF2 Physics 1 Active
US10513503B2 Use of 3-deoxyanthocyanidins for treating occular diseases Human Necessities 1 Active
US9353162B2 Disease-associated proteins Emerging Cross-Sectional Technologies 1 Active
US10519232B2 Agents for use in the treatment of retinal inflammation Chemistry; Metallurgy 1 Active
US10955654B2 Imaging device and method Physics 1 Active
US10668129B2 Synergistic combination of neuronal viability factors and uses thereof Chemistry; Metallurgy 1 Active
US10857239B2 Methods for the treatment and diagnosis of Alzheimer's disease and traumatic brain injuries Physics 0 Active
US11865189B2 Transgenic RPE cells overexpressing OTX2 for the treatment of retinal degeneration Chemistry; Metallurgy 0 Active
US10314804B2 Composition containing norbixin for protecting cells of the retinal pigment epithelium Human Necessities 0 Active
US11072661B2 Agents that inhibit the binding of CFH to CD11 b/CD18 and uses thereof Chemistry; Metallurgy 0 Active
US12215067B2 Chemical compounds targeting the eye and use thereof in the treatment of eye diseases Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.